222 related articles for article (PubMed ID: 12756208)
41. The CYP3A4*1B allele increases risk for small cell lung cancer: effect of gender and smoking dose.
Dally H; Edler L; Jäger B; Schmezer P; Spiegelhalder B; Dienemann H; Drings P; Schulz V; Kayser K; Bartsch H; Risch A
Pharmacogenetics; 2003 Oct; 13(10):607-18. PubMed ID: 14515059
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression.
Gibbs MA; Thummel KE; Shen DD; Kunze KL
Drug Metab Dispos; 1999 Feb; 27(2):180-7. PubMed ID: 9929500
[TBL] [Abstract][Full Text] [Related]
43. The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants.
Zhang J; Kuehl P; Green ED; Touchman JW; Watkins PB; Daly A; Hall SD; Maurel P; Relling M; Brimer C; Yasuda K; Wrighton SA; Hancock M; Kim RB; Strom S; Thummel K; Russell CG; Hudson JR; Schuetz EG; Boguski MS
Pharmacogenetics; 2001 Oct; 11(7):555-72. PubMed ID: 11668216
[TBL] [Abstract][Full Text] [Related]
44. Relative contributions of cytochrome CYP3A4 versus CYP3A5 for CYP3A-cleared drugs assessed in vitro using a CYP3A4-selective inactivator (CYP3cide).
Tseng E; Walsky RL; Luzietti RA; Harris JJ; Kosa RE; Goosen TC; Zientek MA; Obach RS
Drug Metab Dispos; 2014 Jul; 42(7):1163-73. PubMed ID: 24737844
[TBL] [Abstract][Full Text] [Related]
45. Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizole.
Saussele T; Burk O; Blievernicht JK; Klein K; Nussler A; Nussler N; Hengstler JG; Eichelbaum M; Schwab M; Zanger UM
Clin Pharmacol Ther; 2007 Sep; 82(3):265-74. PubMed ID: 17344806
[TBL] [Abstract][Full Text] [Related]
46. Regulation of drug transporter gene expression by nuclear receptors.
Staudinger JL; Madan A; Carol KM; Parkinson A
Drug Metab Dispos; 2003 May; 31(5):523-7. PubMed ID: 12695338
[TBL] [Abstract][Full Text] [Related]
47. Intergenic mRNA molecules resulting from trans-splicing.
Finta C; Zaphiropoulos PG
J Biol Chem; 2002 Feb; 277(8):5882-90. PubMed ID: 11726664
[TBL] [Abstract][Full Text] [Related]
48. No ethnic difference between Caucasian and Japanese hepatic samples in the expression frequency of CYP3A5 and CYP3A7 proteins.
Tateishi T; Watanabe M; Moriya H; Yamaguchi S; Sato T; Kobayashi S
Biochem Pharmacol; 1999 Apr; 57(8):935-9. PubMed ID: 10086328
[TBL] [Abstract][Full Text] [Related]
49. CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population.
Hu YF; He J; Chen GL; Wang D; Liu ZQ; Zhang C; Duan LF; Zhou HH
Clin Chim Acta; 2005 Mar; 353(1-2):187-92. PubMed ID: 15698606
[TBL] [Abstract][Full Text] [Related]
50. Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression.
Sy SK; Ciaccia A; Li W; Roberts EA; Okey A; Kalow W; Tang BK
Eur J Clin Pharmacol; 2002 Aug; 58(5):357-65. PubMed ID: 12185560
[TBL] [Abstract][Full Text] [Related]
51. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators.
Pascussi JM; Drocourt L; Fabre JM; Maurel P; Vilarem MJ
Mol Pharmacol; 2000 Aug; 58(2):361-72. PubMed ID: 10908304
[TBL] [Abstract][Full Text] [Related]
52. Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors.
Betts S; Björkhem-Bergman L; Rane A; Ekström L
Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):261-6. PubMed ID: 25689036
[TBL] [Abstract][Full Text] [Related]
53. Cytochrome P450 3A expression and activity in the rabbit lacrimal gland: glucocorticoid modulation and the impact on androgen metabolism.
Attar M; Ling KH; Tang-Liu DD; Neamati N; Lee VH
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4697-706. PubMed ID: 16303967
[TBL] [Abstract][Full Text] [Related]
54. Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells.
Ohmori S; Nakasa H; Asanome K; Kurose Y; Ishii I; Hosokawa M; Kitada M
Biochim Biophys Acta; 1998 May; 1380(3):297-304. PubMed ID: 9555064
[TBL] [Abstract][Full Text] [Related]
55. Inhibitory anti-CYP3A4 peptide antibody: mapping of inhibitory epitope and specificity toward other CYP3A isoforms.
Wang RW; Newton DJ; Liu NY; Shou M; Rushmore T; Lu AY
Drug Metab Dispos; 1999 Feb; 27(2):167-72. PubMed ID: 9929498
[TBL] [Abstract][Full Text] [Related]
56. Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys.
Uehara S; Murayama N; Nakanishi Y; Zeldin DC; Yamazaki H; Uno Y
J Pharmacol Exp Ther; 2011 Nov; 339(2):654-61. PubMed ID: 21849623
[TBL] [Abstract][Full Text] [Related]
57. Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43.
Westlind A; Malmebo S; Johansson I; Otter C; Andersson TB; Ingelman-Sundberg M; Oscarson M
Biochem Biophys Res Commun; 2001 Mar; 281(5):1349-55. PubMed ID: 11243885
[TBL] [Abstract][Full Text] [Related]
58. Assessment of the impact of CYP3A polymorphisms on the formation of α-hydroxytamoxifen and N-desmethyltamoxifen in human liver microsomes.
Mugundu GM; Sallans L; Guo Y; Shaughnessy EA; Desai PB
Drug Metab Dispos; 2012 Feb; 40(2):389-96. PubMed ID: 22096084
[TBL] [Abstract][Full Text] [Related]
59. Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: differential metabolism by CYP3A4 and CYP3A5.
Cook CS; Berry LM; Kim DH; Burton EG; Hribar JD; Zhang L
Drug Metab Dispos; 2002 Dec; 30(12):1344-51. PubMed ID: 12433801
[TBL] [Abstract][Full Text] [Related]
60. Interindividual Variation in CYP3A Activity Influences Lapatinib Bioactivation.
Bissada JE; Truong V; Abouda AA; Wines KJ; Crouch RD; Jackson KD
Drug Metab Dispos; 2019 Nov; 47(11):1257-1269. PubMed ID: 31492693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
